ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,037.02
-0.07%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Enlivex Therapeutics Ltd (ENLV)

  7. Enlivex Therapeutics Ltd (ENLV) Noticias

ENLV

Enlivex Therapeutics (ENLV)

Enlivex Therapeutics Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ENLV
FechaHoraFuenteTítuloSímboloCompañía
29/04/202407:00GlobeNewswire Inc.Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent EventsNASDAQ:ENLVEnlivex Therapeutics Ltd
22/04/202407:00GlobeNewswire Inc.Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee OsteoarthritisNASDAQ:ENLVEnlivex Therapeutics Ltd
16/04/202415:55AllPennyStocks.comYet Another Biotech Stock Has Found Success During Tuesday's SessionNASDAQ:ENLVEnlivex Therapeutics Ltd
16/04/202406:50GlobeNewswire Inc.Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee OsteoarthritisNASDAQ:ENLVEnlivex Therapeutics Ltd
11/04/202413:58GlobeNewswire Inc.Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with SepsisNASDAQ:ENLVEnlivex Therapeutics Ltd
11/04/202407:05GlobeNewswire Inc.Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With SepsisNASDAQ:ENLVEnlivex Therapeutics Ltd
07/02/202407:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ENLVEnlivex Therapeutics Ltd
07/02/202407:00GlobeNewswire Inc.Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing MethodNASDAQ:ENLVEnlivex Therapeutics Ltd
17/01/202407:00GlobeNewswire Inc.Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee OsteoarthritisNASDAQ:ENLVEnlivex Therapeutics Ltd
26/06/202307:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:ENLVEnlivex Therapeutics Ltd
10/04/202307:01Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ENLVEnlivex Therapeutics Ltd
30/12/202215:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ENLVEnlivex Therapeutics Ltd
01/12/202205:15TipRanksH.C. Wainwright Sticks to Its Buy Rating for Enlivex Therapeutics (ENLV)NASDAQ:ENLVEnlivex Therapeutics Ltd
19/09/202205:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Enlivex Therapeutics (ENLV)NASDAQ:ENLVEnlivex Therapeutics Ltd
30/08/202205:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Enlivex Therapeutics (ENLV)NASDAQ:ENLVEnlivex Therapeutics Ltd
23/08/202205:25TipRanksEnlivex Therapeutics (ENLV) Receives a Buy from H.C. WainwrightNASDAQ:ENLVEnlivex Therapeutics Ltd
08/07/202205:25TipRanksH.C. Wainwright Keeps a Buy Rating on Enlivex Therapeutics (ENLV)NASDAQ:ENLVEnlivex Therapeutics Ltd
25/05/202207:00GlobeNewswire Inc.Enlivex Awarded Its Third Non-Dilutive Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in Sepsis PatientsNASDAQ:ENLVEnlivex Therapeutics Ltd
06/05/202205:10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ENLVEnlivex Therapeutics Ltd
29/04/202207:15Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:ENLVEnlivex Therapeutics Ltd
14/12/202105:27TipRanksEnlivex Therapeutics (ENLV) Gets a Buy Rating from H.C. WainwrightNASDAQ:ENLVEnlivex Therapeutics Ltd
04/06/202115:17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ENLVEnlivex Therapeutics Ltd
18/05/202107:00GlobeNewswire Inc.Enlivex Awarded Second Israel Innovation Authority Grant to Support the Clinical Development of Allocetra in SepsisNASDAQ:ENLVEnlivex Therapeutics Ltd
09/02/202116:22Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ENLVEnlivex Therapeutics Ltd
13/10/202008:17Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:ENLVEnlivex Therapeutics Ltd
01/10/202005:10Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ENLVEnlivex Therapeutics Ltd
13/04/202007:25GlobeNewswire Inc.Enlivex Selected by the Israel Innovation Authority to Receive $1.5 Million Grant to Fund COVID-19 and Sepsis Clinical Trials...NASDAQ:ENLVEnlivex Therapeutics Ltd
18/03/202007:00GlobeNewswire Inc.Enlivex Announces Positive Final Safety and Efficacy Data From Clinical Trial of Off-The-Shelf Allocetra in Patients with Sev...NASDAQ:ENLVEnlivex Therapeutics Ltd
09/03/202007:13GlobeNewswire Inc.Israel Patent Office Grants New Patent Covering Enlivex’s Allocetra Immunotherapy TreatmentNASDAQ:ENLVEnlivex Therapeutics Ltd
05/03/202007:15GlobeNewswire Inc.Enlivex Therapeutics Closes $16.75 Million Registered Direct OfferingNASDAQ:ENLVEnlivex Therapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:ENLV

Su Consulta Reciente

LSE
72BC
Investec Bnk 25
LSE
99LF
Investec Bnk 26
USOTC
PAAFF
Pharmaust (PK)
LSE
45NL
Hsbc Bk. 43
NASDAQ
AMZU
Direxion Daily AMZN Bull...
BOV
V1OD34
Vodafone
BIT
XYLE
S&p 500 Covered Call Uci...
NYSE
IIF
Morgan Stanley India Inv...
LSE
77AR
Investec Bnk 23
LSE
DD71
Citi Fun 25
BIT
XTXC
Xtrackers II iTraxx Cros...
BIT
I07195
INTESA SANPAOLO
ASX
CAMBA
MRTX
BTKBTC
Bitcoin Token
BOV
W1MG34M
Warner Music
BOV
PORT3M
Wilson Sons Holdings Bra... ON
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados